Abbvie Inc (NYSE:ABBV)
| 158.32 Delayed Data As of 4:00pm ET |  -1.30 / -0.81%Today’s Change | 115.10 Today|||52-Week Range 175.91 | +16.93% Year-to-Date |
Latest ABBV News | Press Releases
Today’s Trading
| Previous close | 159.62 |
| Today’s open | 160.00 |
| Day’s range | 157.85 - 160.66 |
| Volume | 3,902,961 |
| Average volume (3 months) | 5,432,840 |
| Market cap | $282.3B |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | +137.07% |
| Earnings growth (this year) | +9.13% |
| Earnings growth (next 5 years) | -1.08% |
| Revenue growth (last year) | +22.69% |
| P/E ratio | 21.1 |
| Price/Sales | 4.28 |
| Price/Book | 18.32 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PFEPfizer | +0.39 | +0.79% |
| MRKMerck | +0.93 | +0.87% |
| LLYEli Lilly and Co | +0.36 | +0.10% |
| AZNAstraZeneca | +0.05 | +0.08% |
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | January 27, 2023 |
| EPS forecast (this quarter) | $3.67 |
| Annual revenue (last year) | $56.2B |
| Annual profit (last year) | $11.5B |
| Net profit margin | 20.41% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters North Chicago, Illinois |
Forecasts
